EuDx-MTB Detection Kit

EuDx-MTB Detection Kit


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
mtb, real-time pcr, detection kit
Category
Clinical Analytical Instrument

EuDiPia Co., Ltd.

Membership
VIP
Country / Year Established
South Korea South Korea / 2012
Business type
Manufacturer
Verified Certificate

10

DUNS

Product name EuDx-MTB Detection Kit Certification -
Category Clinical Analytical Instrument Ingredients -
Keyword mtb , real-time pcr , detection kit Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

EuDx-MTB Detection Kit



│ DESCRIPTION │

EuDx™-MTB detection kit is an in vitro diagnostic reagent for the qualitative detection of M. tuberculosis present in the sputum, urine, tissues and blood of humans as well as in cultured samples using real-time DNA amplification method.
This detection kit is a product based on the nested multiplex real-time PCR method which has high sensitivity and specificity; as such, it is easier to detect small amount of M. tuberculosis while eliminating the problem of false positives and false negatives that may occur in the assays targeting a single DNA using IS6110 and rpoB, the 2 genes that are specific to M. tuberculosis.

  • Detection Technology: One-tube Nested Multiplex Real-time PCR
  • Specimens: sputum, urine, tissues, blood, cultures
  • Target Genes: IS6110 and rpoB (specific to M. tuberculosis)
  • Analytical Sensitivity: 10-102 copies

 



│ FEATURES │

  1. High Performance (Sensitivity & Specificity)
    • Fusion of sensitive PCR techniques (Real-time PCR + Nested PCR)
    • Detection of 2 target genes (Multiplex PCR)
    • Using the highly efficient enzyme
  2. Prevention of Contamination
    • 2 step PCR → One tube test
    • Addition of UDG(Uracil-DNA glycosylase)
  3. Good Stability
    • Long shelf life: 1 year


│ CONTENTS │

  • 2X qPCR Premix
  • Reaction Mixture (Primer/Probe + Internal Control)
  • DNA Extraction Solution (x 4 tubes)
  • Positive Control DNA
  • Nuclease Free Water


│ SPECIFICATION │

  • Compatible Real-Time Thermal Cyclers: ABI 7500, 7500 Fast
  • Size: 96 Test/Kit

 



Product Info Attached File

(EN)EuDiPia_Co.pdf

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

EuDiPia Co., Ltd.

Country / Year Established
South Korea South Korea / 2012
Membership
VIP
Business type
Manufacturer

10

DUNS

President
Kim Insoo
Address
#506,Venture Research Center,194-41 Osongsaengmyeong 1-ro, Osong-eup, Chungweon-gun,Chungcheongbuk-do,363-951,korea
Product Category
Medical Devices
Year Established
2012
No. of Total Employees
1-50
Company introduction

☞ EuDiPia has established the headquarters and a research institute at the business center in Sogang University with a motto of “Diagnostics for Utopia” in September, 2012, and acquired certificate as a venture company from the KOTEC in April, 2013 and in January, 2014 moved into OSONG Medical Innovation Foundation. In June, 2014 EuDiPia has acquired KGMP(Korea Good Manufacturing Practice). 

 

☞ EuDiPia possesses technology named One-tube Nested Multiplex real-time PCR, and the first product using that technology is the EuDxTM-MTB(Mycobacterium tuberculosis). And that has 100 times higher sensitivity compare to threshold cycle value of conventional real-time PCR products. 

 

☞ “EuDxTM-MTB detection” that was registered with trade mark in April, 2013, that a company in partnership, Solgent Co., Ltd. has been consigned for the production of it. After acquired approval from MFDS(Ministry of Food & Drug Safety) in June, 2014 via proceeding of clinical trial in Seoul Asan Hospital, it is scheduled to provide products to large scaled institutions including general hospitals, central laboratories, and Korean Institute of Tuberculosis etc. starting from July, 2014. 

 

☞ Technologies and products to be developed in the future are in the field of respiratory infectious diseases first and then covering other infectious viruses like hepatitis and HPVs etc. . It is planned to make a fully automated POCT system that is with improved convenience for users and also accuracy. 

 

☞ For entering to the market, local distributors are to be involved for Korean market. And in case of China, the joint corporation is planned to be established. In addition, it is scheduled to establish country-specific trade route for emerging markets in other foreign countries. Achieves sales amount of ten billion won within 5 years since the first product is launched.

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more